Richard Bucala

47.4k total citations · 13 hit papers
405 papers, 37.5k citations indexed

About

Richard Bucala is a scholar working on Immunology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, Richard Bucala has authored 405 papers receiving a total of 37.5k indexed citations (citations by other indexed papers that have themselves been cited), including 282 papers in Immunology, 126 papers in Cellular and Molecular Neuroscience and 57 papers in Clinical Biochemistry. Recurrent topics in Richard Bucala's work include Macrophage Migration Inhibitory Factor (255 papers), Nuclear Receptors and Signaling (123 papers) and Advanced Glycation End Products research (55 papers). Richard Bucala is often cited by papers focused on Macrophage Migration Inhibitory Factor (255 papers), Nuclear Receptors and Signaling (123 papers) and Advanced Glycation End Products research (55 papers). Richard Bucala collaborates with scholars based in United States, Germany and China. Richard Bucala's co-authors include Anthony Cerami, Lin Leng, Helen Vlassara, Christine N. Metz, Jürgen Bernhagen, Jason Chesney, Thierry Calandra, Michael Bacher, Seamas C. Donnelly and Zenji Makita and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Richard Bucala

403 papers receiving 36.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

2005 1.2k citations Daniel R. Goldstein, Richard Bucala et al. profile →
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair

1994 1.0k citations Richard Bucala et al. profile →
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

2007 990 citations Jürgen Bernhagen, Lin Leng et al. profile →
MIF as a glucocorticoid-induced modulator of cytokine production

1995 969 citations Jürgen Bernhagen, Christine N. Metz et al. profile →
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

1991 962 citations Richard Bucala et al. profile →
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites

2001 802 citations Seamas C. Donnelly, Richard Bucala et al. The Journal of Immunology profile →
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

1994 753 citations Richard Bucala et al. profile →
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

1994 686 citations Richard Bucala et al. profile →
Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy

1997 635 citations Richard Bucala et al. profile →
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

1996 589 citations Christine N. Metz, Richard Bucala et al. profile →
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View

2013 576 citations Jürgen Bernhagen, Richard Bucala et al. profile →
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex

2006 530 citations Lin Leng, Courtney McDonald et al. profile →
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response

2001 508 citations Robert A. Mitchell, Günter Fingerle‐Rowson et al. profile →

Peers

Countries citing papers authored by Richard Bucala

Since Specialization

Citations

This map shows the geographic impact of Richard Bucala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bucala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bucala more than expected).

Fields of papers citing papers by Richard Bucala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bucala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bucala. The network helps show where Richard Bucala may publish in the future.

Co-authorship network of co-authors of Richard Bucala

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bucala. A scholar is included among the top collaborators of Richard Bucala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bucala. Richard Bucala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1 2025 ·JCI Insight ·Thuy Tran, (unknown), Lais Osmani, (unknown), (unknown), Marta Piecychna, Lin Leng, Michelle E. Armstrong, Seamas C. Donnelly, Carlo Bifulco, Terri Clister, Rajan P. Kulkarni, Lin Zhang, Mario Sznol, Lucia B. Jilaveanu, Harriet M. Kluger, Insoo Kang, Richard Bucala	0
2	A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation 2024 ·Metabolism ·Hao Wang, (unknown), (unknown), Zehui Li, Lin Leng, Bi Zhao, Richard Bucala, Ji Li	11
3	Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia 2024 ·JCI Insight ·(unknown), Liujun Chen, (unknown), (unknown), Haibin Tong, Hong Wu, (unknown), Lin Leng, Sukhinder Kaur Cheema, Guang Sun, Zhengyuan Xia, John J. McGuire, Brian Rodrigues, (unknown), Richard Bucala, Dake Qi	8
4	A small-molecule allele-selective transcriptional inhibitor of the MIF immune susceptibility locus 2024 ·Journal of Biological Chemistry ·Jia Li, Lin Leng, Georgios Pantouris, R. Manjula, Marta Piecychna, Laura Abriola, Buqu Hu, Elias Lolis, Michelle E. Armstrong, Seamas C. Donnelly, Richard Bucala	2
5	830 Inhibition of macrophage migration inhibitory factor (MIF) to overcome immune checkpoint resistance in melanoma 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Lin Leng, Lin Zhang, Lucia B. Jilaveanu, Harriet M. Kluger, Richard Bucala, Thuy Tran	1
6	Urothelial Oxidative Stress and ERK Activation Mediate HMGB1-Induced Bladder Pain 2023 ·Cells ·Shaojing Ye, (unknown), Fei Ma, Lin Leng, Richard Bucala, Pedro L. Vera	7
7	Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection 2022 ·Viruses ·(unknown), (unknown), (unknown), (unknown), Lin Leng, Natalia Laufer, María Florencia Quiroga, Richard Bucala, Yanina Ghiglione, Gabriela Turk	4
8	Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice 2021 ·Cellular Immunology ·Arthur A. Vandenbark, Roberto Meza‐Romero, Jack Wiedrick, (unknown), (unknown), Gail Kent, Hilary Seifert, Gil Benedek, Richard Bucala, Halina Offner	6
9	Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis 2021 ·JCI Insight ·Kyle L. Poulsen, Xiude Fan, (unknown), Emily Huang, Xiaoqin Wu, Megan R. McMullen, Lin Leng, Richard Bucala, Meritxell Ventura‐Cots, Josepmaria Argemí, Ramón Bataller, Laura E. Nagy	12
10	Extracellular MIF, but not its homologue D-DT, promotes fibroblast motility independently of its receptor complex CD74/CD44 2020 ·Journal of Cell Science ·(unknown), (unknown), Suada Fröhlich, Uwe Plessmann, Henning Urlaub, Lin Leng, Richard Bucala, Robert Grosse, Andreas Meinhardt, Jörg Klug	3
11	The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery 2020 ·Journal of Clinical Medicine ·Luisa Averdunk, Jürgen Bernhagen, (unknown), Harald Surowy, Hermann‐Josef Lüdecke, Sören Mucha, Patrick Meybohm, Dagmar Wieczorek, Lin Leng, Gernot Marx, David E. Leaf, Alexander Zarbock, Kai Zacharowski, (unknown), Richard Bucala, Christian Stoppe	13
12	Macrophage migration inhibitory factor enhances influenza-associated mortality in mice 2019 ·JCI Insight ·Candice A. Smith, (unknown), Upasana Kulkarni, Sherri C. Wood, Lin Leng, Rachel L. Zemans, Richard Bucala, Daniel R. Goldstein	16
13	Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico 2019 ·Molecular Genetics & Genomic Medicine ·(unknown), (unknown), José Eduardo Navarro‐Zarza, Jorge Hernández‐Bello, Richard Bucala, (unknown), (unknown), Isela Parra‐Rojas, Berenice Illades‐Aguiar, José Francisco Muñóz-Valle	8
14	T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell–Cell Contact Mediated through SLAMF6 and SAP 2017 ·The Journal of Immunology ·Lihi Radomir, Sivan Cohen, Matthias P. Kramer, (unknown), Hadas Lewinsky, (unknown), Ziv Porat, Richard Bucala, Polina Stepensky, Shirly Becker-Herman, Idit Shachar	19
15	Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis 2015 ·Cytokine ·Ran Gu, Leilani L. Santos, Devi Ngo, Huapeng Fan, (unknown), Günter Fingerle‐Rowson, Richard Bucala, Jiake Xu, Julian M.W. Quinn, Eric F. Morand	36
16	MIF Produced by Bone Marrow–Derived Macrophages Contributes to Teratoma Progression after Embryonic Stem Cell Transplantation 2012 ·Cancer Research ·Xi Wang, Tianxiang Chen, Lin Leng, Jianqing Fan, Kai Cao, Zhaoxia Duan, Xijing Zhang, Changshun Shao, (unknown), Iman Tadmori, Tianyi Li, Liang Li, Dongming Sun, Shusen Zheng, Andreas Meinhardt, Wise Young, Richard Bucala, Yi Ren	39
17	A Novel, Macrophage Migration Inhibitory Factor Suicide Substrate Inhibits Motility and Growth of Lung Cancer Cells 2008 ·Cancer Research ·(unknown), (unknown), Swen Zierow, Beatriz E. Rendon, G.V. Crichlow, (unknown), Richard Bucala, Lin Leng, Ned B. Smith, Elias Lolis, John O. Trent, Robert A. Mitchell	133
18	A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia 2006 ·The Journal of Experimental Medicine ·Michael A. McDevitt, Jianlin Xie, Shanmugasundaram Ganapathy‐Kanniappan, Jason W. Griffith, Aihua Liu, Courtney McDonald, Philip E. Thuma, Victor R. Gordeuk, Christine N. Metz, Robert A. Mitchell, Jeffrey R. Keefer, John R. David, Lin Leng, Richard Bucala	108
19	[11] Advanced glycation end products: Detection and reversal 1999 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Yousef Al‐Abed, Aphrodite Kapurniotu, Richard Bucala	33
20	Lipid and lipoprotein oxidation: basic mechanisms and unresolved questions in vivo 1996 ·Redox Report ·Richard Bucala	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact